Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Signaling mechanisms in the nitric oxide donor and amphetamine-induced dopamine release in mesencephalic primary cultured neurons (2016)

  • Authors:
  • USP affiliated authors: GUIMARAES, ELAINE APARECIDA DEL BEL BELLUZ - FORP
  • USP Schools: FORP
  • DOI: 10.1007/s12640-015-9562-8
  • Subjects: ÓXIDO NÍTRICO; NEUROENDOCRINOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s12640-015-9562-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s12640-015-9562-8 (Fonte: Unpaywall API)

    Título do periódico: Neurotoxicity Research

    ISSN: 1029-8428,1476-3524



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Neurotoxicity Research

    ISSN: 1029-8428

    Citescore - 2017: 3.01

    SJR - 2017: 1.063

    SNIP - 2017: 0.807


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FORP2739893pcd 2739893 Estantes Deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SALUM, Cristiane; SCHMIDT, Fanny; MICHEL, Patrick P.; DEL BEL, Elaine Aparecida; RAISMAN-VOZARI, Rita. Signaling mechanisms in the nitric oxide donor and amphetamine-induced dopamine release in mesencephalic primary cultured neurons. Neurotoxicity Research, New York, v. 29, n. 1, p. 92–104, 2016. Disponível em: < http://dx.doi.org/10.1007/s12640-015-9562-8 > DOI: 10.1007/s12640-015-9562-8.
    • APA

      Salum, C., Schmidt, F., Michel, P. P., Del Bel, E. A., & Raisman-Vozari, R. (2016). Signaling mechanisms in the nitric oxide donor and amphetamine-induced dopamine release in mesencephalic primary cultured neurons. Neurotoxicity Research, 29( 1), 92–104. doi:10.1007/s12640-015-9562-8
    • NLM

      Salum C, Schmidt F, Michel PP, Del Bel EA, Raisman-Vozari R. Signaling mechanisms in the nitric oxide donor and amphetamine-induced dopamine release in mesencephalic primary cultured neurons [Internet]. Neurotoxicity Research. 2016 ; 29( 1): 92–104.Available from: http://dx.doi.org/10.1007/s12640-015-9562-8
    • Vancouver

      Salum C, Schmidt F, Michel PP, Del Bel EA, Raisman-Vozari R. Signaling mechanisms in the nitric oxide donor and amphetamine-induced dopamine release in mesencephalic primary cultured neurons [Internet]. Neurotoxicity Research. 2016 ; 29( 1): 92–104.Available from: http://dx.doi.org/10.1007/s12640-015-9562-8

    Referências citadas na obra
    Aga RG, Hughes MN (2008) The preparation and purification of NO gas and the use of NO releasers: the application of NO donors and other agents of nitrosative stress in biological systems. Methods Enzymol 436:35–48. doi: 10.1016/S0076-6879(08)36003-0
    Antunes F, Nunes C, Laranjinha J, Cadenas E (2005) Redox interactions of nitric oxide with dopamine and its derivatives. Toxicology 208:207–212
    Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480–6491
    Berk M, Malhi GS, Gray LJ, Dean OM (2013) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34:167–177. doi: 10.1016/j.tips.2013.01.001
    Bernstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. SchizophrRes 78:69–86
    Bernstein HG, Becker A, Keilhoff G, Grecksch G, Bogerts B (2011) Schizophrenia and the nitric oxide controversy: do all things fall into place now? Synapse 65:545–546. doi: 10.1002/syn.20871 author reply 547
    Bowyer JF, Clausing P, Gough B, Slikker W Jr, Holson RR (1995) Nitric oxide regulation of methamphetamine-induced dopamine release in caudate/putamen. Brain Res 699:62–70
    Brown GC (2010) Nitric oxide and neuronal death. Nitric Oxide 23:153–165. doi: 10.1016/j.niox.2010.06.001
    Cadet JL, Bisagno V, Milroy CM (2014) Neuropathology of substance use disorders. Acta Neuropathol 127:91–107. doi: 10.1007/s00401-013-1221-7
    Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766–775. doi: 10.1038/nrn2214
    Calipari ES, Ferris MJ, Siciliano CA, Jones SR (2015) Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate. ACS Chem Neurosci 6:155–162. doi: 10.1021/cn500262x
    Canals S, Casarejos MJ, Rodriguez-Martin E, de Bernardo S, Mena MA (2001) Neurotrophic and neurotoxic effects of nitric oxide on fetal midbrain cultures. J Neurochem 76:56–68
    Chaparro-Huerta V, Beas-Zarate C, Guerrero MU, Feria-Velasco A (1997) Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem Int 31:607–616
    Clarke PB, Reuben M (1995) Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Br J Pharmacol 114:315–322
    Daveu C, Servy C, Dendane M, Marin P, Ducrocq C (1997) Oxidation and nitration of catecholamines by nitrogen oxides derived from nitric oxide. Nitric Oxide 1:234–243
    Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698
    Freudenberg F, Alttoa A, Reif A (2015) Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav 14:46–63. doi: 10.1111/gbb.12193
    Friend DM, Fricks-Gleason AN, Keefe KA (2014) Is there a role for nitric oxide in methamphetamine-induced dopamine terminal degeneration? Neurotox Res 25:153–160. doi: 10.1007/s12640-013-9415-2
    Garthwaite J (2008) Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783–2802. doi: 10.1111/j.1460-9568.2008.06285.x
    Gere-Paszti E, Jakus J (2009) The effect of N-acetylcysteine on amphetamine-mediated dopamine release in rat brain striatal slices by ion-pair reversed-phase high performance liquid chromatography. Biomed Chromatogr 23:658–664. doi: 10.1002/bmc.1171
    Guevara-Guzman R, Emson PC, Kendrick KM (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J Neurochem 62:807–810
    Guix FX, Uribesalgo I, Coma M, Munoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126–152
    Hallak JE, Maia-de-Oliveira JP, Abrao J, Evora PR, Zuardi AW, Crippa JA, Belmonte-de-Abreu P, Baker GB, Dursun SM (2013) Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry 70:668–676. doi: 10.1001/jamapsychiatry.2013.1292
    Halmos G, Horvath T, Polony G, Fekete A, Kittel A, Vizi ES, van der Laan BF, Zelles T, Lendvai B (2008) The role of N-methyl-d-aspartate receptors and nitric oxide in cochlear dopamine release. Neuroscience 154:796–803. doi: 10.1016/j.neuroscience.2008.03.071
    Hanbauer I, Wink D, Osawa Y, Edelman GM, Gally JA (1992) Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport 3:409–412
    Harro J (2015) Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol 120:179–204. doi: 10.1016/bs.irn.2015.02.004
    Hartikka J, Hefti F (1988) Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci 8:2967–2985
    Hartung H, Threlfell S, Cragg SJ (2011) Nitric oxide donors enhance the frequency dependence of dopamine release in nucleus accumbens. Neuropsychopharmacology 36:1811–1822. doi: 10.1038/npp.2011.62
    Hastings TG (2009) The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease. J Bioenerg Biomembr 41:469–472. doi: 10.1007/s10863-009-9257-z
    Issy AC, Salum C, Del Bel EA (2009) Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice. Behav Brain Res 205:475–481. doi: 10.1016/j.bbr.2009.08.003
    Itzhak Y, Ali SF (2006) Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol Ther 109:246–262. doi: 10.1016/j.pharmthera.2005.08.004
    Kashihara K, Hamamura T, Okumura K, Otsuki S (1990) Effect of MK-801 on endogenous dopamine release in vivo. Brain Res 528:80–82
    Kiss JP, Vizi ES (2001) Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24:211–215
    Kiss JP, Zsilla G, Vizi ES (2004) Inhibitory effect of nitric oxide on dopamine transporters: interneuronal communication without receptors. Neurochem Int 45:485–489
    Knusel B, Michel PP, Schwaber JS, Hefti F (1990) Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 10:558–570
    Krystal JH, Perry EB Jr, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D’Souza DC (2005) Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Arch Gen Psychiatry 62:985–994. doi: 10.1001/archpsyc.62.9.985
    Laruelle M, bi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235–9240
    Lee DK, Oh JH, Shim YB, Choe ES (2013) Protein kinase G regulates dopamine release, DeltaFosB expression, and locomotor activity after repeated cocaine administration: involvement of dopamine D2 receptors. Neurochem Res 38:1424–1433. doi: 10.1007/s11064-013-1040-1
    Liddie S, Balda MA, Itzhak Y (2013) Nitric oxide (NO) signaling as a potential therapeutic modality against psychostimulants. Curr Pharm Des 19:7092–7102
    Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK (1991) Complexes of.NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242–3247
    Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706–8711
    McCann UD, Ricaurte GA (2004) Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci Biobehav Rev 27:821–826. doi: 10.1016/j.neubiorev.2003.11.003
    Michel PP, Agid Y (1996) Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 67:1633–1642
    Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26:428–435. doi: 10.1002/jnr.490260405
    Michel PP, Vyas S, Agid Y (1992) Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains. J Neurochem 59:118–127
    Michel PP, Ruberg M, Agid Y (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 69:1499–1507
    Minutolo G, Petralia A, Dipasquale S, Aguglia E (2012) Nitric oxide in patients with schizophrenia: the relationship with the severity of illness and the antipsychotic treatment. Expert Opin Pharmacother 13:1989–1997. doi: 10.1517/14656566.2012.713346
    Moldzio R, Radad K, Duvigneau JC, Kranner B, Krewenka C, Piskernik C, Rausch WD (2006) Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture. J Neural Transm 113:1095–1105. doi: 10.1007/s00702-005-0394-1
    Nakagawa T, Suzuki Y, Nagayasu K, Kitaichi M, Shirakawa H, Kaneko S (2011) Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLoS One 6:e24865. doi: 10.1371/journal.pone.0024865
    Nowak P, Brus R, Oswiecimska J, Sokola A, Kostrzewa RM (2002) 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. an in vivo microdialysis and voltammetric study. J Physiol Pharmacol 53:251–263
    Oster S, Radad K, Scheller D, Hesse M, Balanzew W, Reichmann H, Gille G (2014) Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. Eur J Pharmacol 724:31–42. doi: 10.1016/j.ejphar.2013.12.014
    Pereira DB, Sulzer D (2012) Mechanisms of dopamine quantal size regulation. Front Biosci 17:2740–2767
    Perfeito R, Cunha-Oliveira T, Rego AC (2013) Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med 62:186–201. doi: 10.1016/j.freeradbiomed.2013.05.042
    Robertson SD, Matthies HJ, Galli A (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39:73–80. doi: 10.1007/s12035-009-8053-4
    Rocchitta G, Migheli R, Mura MP, Grella G, Esposito G, Marchetti B, Miele E, Desole MS, Miele M, Serra PA (2005) Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats: role of extracellular Ca2+ and l-type Ca2+ channels. Brain Res 1047:18–29. doi: 10.1016/j.brainres.2005.04.008
    Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, Michel PP (2004) Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci 24:5922–5930. doi: 10.1523/JNEUROSCI.5668-03.2004
    Salum C, Guimaraes FS, Brandao ML, Del Bel EA (2006) Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat. Psychopharmacology 185:133–141. doi: 10.1007/s00213-005-0277-z
    Salum C, Raisman-Vozari R, Michel PP, Gomes MZ, Mitkoviski M, Ferrario JE, Ginestet L, Del Bel EA (2008) Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons. Brain Res 1198:27–33
    Sammut S, Park DJ, West AR (2007) Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS-dependent mechanism. J Neurochem 103:1145–1156. doi: 10.1111/j.1471-4159.2007.04811.x
    Serra PA, Rocchitta G, Delogu MR, Migheli R, Taras MG, Mura MP, Esposito G, Miele E, Desole MS, Miele M (2003) Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study. J Neurochem 86:1403–1413
    Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2014) Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci 34:5575–5582. doi: 10.1523/JNEUROSCI.4050-13.2014
    Smythies J (1999) The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion. Neurotox Res 1:27–39
    Snyder SH, Ferris CD (2000) Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry 11:1738–1751
    Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406–433
    Sun J, Xu L, Eu JP, Stamler JS, Meissner G (2003) Nitric oxide, NOC-12, and S-nitrosoglutathione modulate the skeletal muscle calcium release channel/ryanodine receptor by different mechanisms. An allosteric function for O2 in S-nitrosylation of the channel. J Biol Chem 278:8184–8189. doi: 10.1074/jbc.M211940200
    Takahata K, Katsuki H, Kume T, Ito K, Tochikawa Y, Muraoka S, Yoneda F, Kashii S, Honda Y, Akaike A (2003) Retinal neurotoxicity of nitric oxide donors with different half-life of nitric oxide release: involvement of N-methyl-d-aspartate receptor. J Pharmacol Sci 92:428–432
    Taneli F, Pirildar S, Akdeniz F, Uyanik BS, Ari Z (2004) Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia. Arch Med Res 35:401–405. doi: 10.1016/j.arcmed.2004.06.002
    Trabace L, Kendrick KM (2000) Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J Neurochem 75:1664–1674
    Traver S, Salthun-Lassalle B, Marien M, Hirsch EC, Colpaert F, Michel PP (2005) The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol 67:1882–1891. doi: 10.1124/mol.104.007864
    Volz TJ, Schenk JO (2004) l-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism. Synapse 54:173–182
    West AR, Galloway MP (1997) Endogenous nitric oxide facilitates striatle dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 279:1571–1581
    West AR, Galloway MP (1998) Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms. Neurochem Int 33:493–501
    West AR, Galloway MP, Grace AA (2002) Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 44:227–245
    Whitton PS, Maione S, Biggs CS, Fowler LJ (1994) N-methyl-d-aspartate receptors modulate extracellular dopamine concentration and metabolism in rat hippocampus and striatum in vivo. Brain Res 635:312–316
    Wink DA, Mitchell JB (1998) Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25:434–456
    Yu S, Zhu L, Shen Q, Bai X, Di X (2015) Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology. Behav Neurol 2015:103969. doi: 10.1155/2015/103969
    Zhu XZ, Luo LG (1992) Effect of nitroprusside(nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem 59:932–935